Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company..
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company..
*TORONTO, ON / ACCESSWIRE / March 27, 2024 /* Theralase® Technologies Inc. ("*Theralase®*" or the "*Company*")..
The global Healthcare Contract Research Organization Market size and share is currently valued at USD 48.16 billion in 2023. It is..